The Novel SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in a Phase 2a Study in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Horwitz Steven M.; Feldman Tatyana A.; Hess Brian T.; Khodadoust Michael S.; Kim Youn H.; Munoz Javier; Patel Manish R.; Phillips Tycel J.; Smith Stephen D.; Smith Sonali M.; Wilcox Ryan A.; Steele Andrew; Pandey Anjali; Birrell Matt R.; Leeds Janet M.; Conley Pamela B.; Michelson Glenn; Coffey Gregory P.; Curnutte John T.; Hamlin Paul A.;

  展开▼
• 作者单位

  Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

  Hackensack Univ Med Ctr Hackensack NJ USA;

  Med Univ South Carolina Hollings Med Canc Ctr Div Hematol Oncol Charleston SC 29425 USA;

  Stanford Univ Med Ctr Stanford CA 94305 USA;

  Stanford Univ Med Ctr Stanford CA 94305 USA;

  Banner MD Anderson Canc Ctr Gilbert AZ USA;

  Florida Canc Specialists Sarah Cannon Res Inst Drug Dev Unit Sarasota FL USA;

  Univ Michigan Ctr Canc Dexter MI USA;

  Univ Washington Seattle Canc Care Alliance Seattle WA 98195 USA;

  Univ Chicago Med Chicago IL USA;

  Univ Michigan Ctr Canc Ann Arbor MI 48109 USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Portola Pharmaceut R&

  D San Francisco CA USA;

  Mem Sloan Kettering Canc Ctr Dept Med Oncol 1275 York Ave New York NY 10021 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词